Oct. 1, 2003
Bayer fellowship grant to support graduate fellows in coagulation research
CHAPEL HILL — Bayer Biological Products officials have awarded a grant to the University of North Carolina at Chapel Hill’s Center for Thrombosis and Hemostasis that will enhance a program supporting postdoctoral or graduate fellows pursuing careers in coagulation-disorder research.
The $75,000 grant is a part of the Bayer Corp. Fellowship Fund, a three-year-old cooperative effort in treating blood-related diseases and disorders that involves Bayer BP and the UNC center. Dr. Peter Larson, director of global clinical strategy, and Jamelle Barnes, deputy director of scientific relations-coagulation, both of Bayer BP, announced the gift at the UNC School of Medicine’s recent Clotting Factor Inhibitors Symposium.
“We are deeply appreciative of Bayer BP’s investment in helping train tomorrow’s leaders in coagulation research and clinical care,” said Dr. Gilbert White, director of the UNC center. “The distinguished position our center holds today in this area can be attributed in part to the years of unwavering commitment of partners such as Bayer BP.”
White and Dr. Harold Roberts, Sarah Graham Kenan distinguished professor of medicine at UNC, serve as mentors for the Bayer fellows.
“Having trained under these two outstanding researchers, I feel this is a significant opportunity for young researchers who are interested in coagulation,” said Larson. “I am also proud that, as a global leader in this therapeutic area, Bayer BP supports opportunities for gifted young researchers to pursue critical research in this area.”
White serves as chairman of the grants review committee for the Bayer Hemophilia Awards Program. The global program, the largest of its kind, was initiated in 2002 and provides annual grants totaling $2.75 million to early career investigators, fellows in training and other hemophilia care professionals. The company recently announced the first recipients.
Past recipients of the Bayer Corp. Fellowship Fund have focused their research on biochemistry of coagulation and platelet research, among other areas.
Dr. Alisa Wolberg, a past Bayer Corporate Fellow, said she was honored to have been a recipient of the grant. “The fellowship has enabled me to pursue my research interests in this very important area and also to interact with world-renowned hematology researchers at UNC and Bayer BP.”
Bayer Biological Products is part of the worldwide operations of Bayer HealthCare, a subgroup of Bayer AG. Bayer HealthCare is one of the world’s leading innovators in the health care and medical products industries.
The Bayer BP grant counts toward the Carolina First campaign goal of $1.8 billion. Carolina First is a comprehensive, multi-year private fund-raising campaign to support Carolina’s vision of becoming the nation’s leading public university.
Bayer BP contact: Tricia McKernan, (919) 316-6316 or email@example.com
UNC News Services contact: Deb Saine, (919) 962-8415 or firstname.lastname@example.org